Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 21, 2012

View Archived Issues

PaxVax presents phase I results on single-dose live oral cholera vaccine

A novel bispecific antibody shows tumor specificity in vivo

Lipoquin provides protection in murine model of pneumonic plague

Researchers at Bayer synthesize new cyclin-dependent kinase inhibitors

Oxford BioMedica provides update on ocular gene therapy candidates

FDA recommends continuation of Emmaus Medical's phase III sickle cell disease study

Astellas files sNDA for Tarceva in specific NSCLC subtype

European Commission approves Bayer's oral anticoagulant Xarelto for new indication

LEO Pharma's Picato gel receives European approval for actinic keratosis

Neovacs discloses final results from phase II TNF-alpha kinoid study

RNAi modifications: Progression from the bench to the clinic

Antisense morpholinos devised to treat spinal muscular atrophy

Dicerna's Dicer Substrate siRNA in lipid nanoparticles targets beta-catenin

Bayer Intellectual Property patents novel GCS activators

New C. difficile vaccines patented by Pfizer

GlaxoSmithKline synthesizes new bromodomain inhibitors

Ancora Pharmaceuticals presents new vaccines for Staphylococcus infection

New bispecific antibodies for cancer prepared by Genmab

Regen BioPharma begins preclinical study of HemaXellerate cell therapy

Atox Bio releases encouraging phase IIa topline results for AB-103

TMZ-POH has cytotoxic effects in temozolomide-resistant glioma cell lines

Preclinical study of H5N1 VLP vaccine shows cross-protection effects

European Commission approves Eliquis to prevent stroke in nonvalvular atrial fibrillation

Supernus' antiepileptic drug granted 3 years of market exclusivity in U.S.

XBiotech reports on interim analysis from phase II trial of monoclonal antibody

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Autobahn on the fast track with bipolar thyroid agonist
BioWorld
Achieving high marks in the phase II Amplify-BD trial for bipolar I and II depression, Autobahn Therapeutics Inc.’s elunetirom, a brain-penetrant central nervous...